在神经母细胞瘤中,早期的进化分支跨越空间域倾向于在化疗下进行克隆替代
Jenny Karlsson1, Hiroaki Yasui1,2, Adriana Mañas3
1Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Nature communications
|October 17, 2024
概括
儿童神经母细胞瘤 (NB) 治疗耐药性与癌细胞进化有关. 有效的化疗可以用遥远的幸存者取代占主导地位的癌症细胞系,而进展的瘤显示早期出现的祖先推动了后来的生长.
科学领域:
- 在瘤学瘤学.
- 癌症基因组学 癌症基因组学
- 发展生物学 发展生物学
背景情况:
- 神经母细胞瘤 (NB) 是一种致命的儿科癌症,具有高耐治疗性.
- 了解NB在治疗过程中的演变对于改善结果至关重要.
研究的目的:
- 研究化疗前后神经母细胞瘤亚克隆的空间和进化动态.
- 根据治疗和疾病进展,确定不同的进化轨迹.
主要方法:
- 来自12例神经母细胞瘤病例的89个瘤区域的空间映射.
- 505个单个NB细胞的全基因组测序.
- 化疗处理的异种移植和细胞培养模型.
主要成果:
- 有效的化疗诱导了从密集,相关的亚克隆转变为稀疏,远距离相关的幸存者亚克隆.
- 在治疗过程中进展的瘤显示了后来的主导子克隆的先前存在的祖先.
- 观察到分支进化和丰富的并行亚克隆的剧目,起源于早期的瘤发生.
结论:
- 神经母细胞瘤的治疗反应的特征是由独特的进化路径驱动的克隆替代.
- 多种不同亚克隆的早期出现为治疗耐药性和复发提供了基础.
- 这些发现强调了针对神经母细胞瘤早期进化事件的重要性.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K


